Andreas Meisel

23.0k total citations · 7 hit papers
317 papers, 15.6k citations indexed

About

Andreas Meisel is a scholar working on Neurology, Epidemiology and Molecular Biology. According to data from OpenAlex, Andreas Meisel has authored 317 papers receiving a total of 15.6k indexed citations (citations by other indexed papers that have themselves been cited), including 140 papers in Neurology, 74 papers in Epidemiology and 53 papers in Molecular Biology. Recurrent topics in Andreas Meisel's work include Myasthenia Gravis and Thymoma (97 papers), Acute Ischemic Stroke Management (57 papers) and Peripheral Neuropathies and Disorders (55 papers). Andreas Meisel is often cited by papers focused on Myasthenia Gravis and Thymoma (97 papers), Acute Ischemic Stroke Management (57 papers) and Peripheral Neuropathies and Disorders (55 papers). Andreas Meisel collaborates with scholars based in Germany, United States and United Kingdom. Andreas Meisel's co-authors include Ulrich Dirnagl, Christian Meisel, Philipp Mergenthaler, Konstantin Prass, Ute Lindauer, Karsten Ruscher, Gerald A. Dienel, Josef Priller, Hendrik Harms and Jan M. Schwab and has published in prestigious journals such as Nature, New England Journal of Medicine and Proceedings of the National Academy of Sciences.

In The Last Decade

Andreas Meisel

298 papers receiving 15.4k citations

Hit Papers

Sugar for the brain: the role of glucose in phys... 2003 2026 2010 2018 2013 2005 2003 2012 2009 250 500 750 1000
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Sugar for the brain: the role of glucose in physiological and pathological brain function
    2013 1.1k citations Philipp Mergenthaler, Andreas Meisel et al. profile →
  2. Central nervous system injury-induced immune deficiency syndrome
    2005 718 citations Christian Meisel, Andreas Meisel et al. profile →
  3. Stroke-induced Immunodeficiency Promotes Spontaneous Bacterial Infections and Is Mediated by Sympathetic Activation Reversal by Poststroke T Helper Cell Type 1–like Immunostimulation
    2003 718 citations Christian Meisel, Andreas Meisel et al. profile →
  4. The immunology of acute stroke
    2012 516 citations Andreas Meisel et al. profile →
  5. Preconditioning and tolerance against cerebral ischaemia: from experimental strategies to clinical use
    2009 479 citations Andreas Meisel et al. profile →
  6. Diagnosis of Stroke-Associated Pneumonia
    2015 314 citations Joan Montaner, Andreas Meisel et al. profile →
  7. Long-term safety, tolerability, and efficacy of efgartigimod (ADAPT+): interim results from a phase 3 open-label extension study in participants with generalized myasthenia gravis
    2024 36 citations James F. Howard, Vera Bril et al. Frontiers in Neurology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Andreas Meisel Germany 63 4.3k 4.1k 3.7k 3.5k 2.0k 317 15.6k
Christoph Kleinschnitz Germany 62 3.6k 0.8× 3.4k 0.8× 2.0k 0.5× 2.3k 0.7× 2.3k 1.1× 440 13.8k
José Castillo Spain 69 3.9k 0.9× 3.6k 0.9× 3.7k 1.0× 6.0k 1.7× 1.1k 0.5× 355 15.3k
Anna M. Planas Spain 64 5.8k 1.3× 4.5k 1.1× 1.7k 0.5× 3.2k 0.9× 2.8k 1.4× 233 14.4k
Klaus Faßbender Germany 61 2.7k 0.6× 3.4k 0.8× 3.5k 1.0× 2.6k 0.8× 1.3k 0.7× 263 12.5k
Matthias Endres Germany 81 4.0k 0.9× 6.8k 1.7× 3.7k 1.0× 5.5k 1.6× 1.8k 0.9× 560 24.1k
Patricia D. Hurn United States 71 4.5k 1.1× 4.5k 1.1× 1.8k 0.5× 2.1k 0.6× 1.6k 0.8× 182 16.1k
Gary A. Rosenberg United States 68 6.8k 1.6× 5.1k 1.3× 4.2k 1.1× 3.9k 1.1× 1.1k 0.5× 201 19.5k
Chung Y. Hsu Taiwan 69 3.1k 0.7× 5.8k 1.4× 3.0k 0.8× 3.1k 0.9× 955 0.5× 468 19.8k
Jacques De Keyser Netherlands 61 2.0k 0.5× 2.3k 0.6× 3.1k 0.8× 3.0k 0.9× 978 0.5× 329 12.8k
Josef Anrather United States 64 5.9k 1.4× 5.5k 1.3× 1.9k 0.5× 1.8k 0.5× 3.0k 1.5× 126 15.4k

Countries citing papers authored by Andreas Meisel

Since Specialization
Citations

This map shows the geographic impact of Andreas Meisel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andreas Meisel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andreas Meisel more than expected).

Fields of papers citing papers by Andreas Meisel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andreas Meisel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andreas Meisel. The network helps show where Andreas Meisel may publish in the future.

Co-authorship network of co-authors of Andreas Meisel

This figure shows the co-authorship network connecting the top 25 collaborators of Andreas Meisel. A scholar is included among the top collaborators of Andreas Meisel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andreas Meisel. Andreas Meisel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gerischer, Lea, et al.. (2025). New and Emerging Biological Therapies for Myasthenia Gravis: A Focussed Review for Clinical Decision-Making. BioDrugs. 39(2). 185–213. 3 indexed citations
2.
3.
Stascheit, Frauke, Annette Aigner, Christian W. Keller, et al.. (2024). Ravulizumab and Efgartigimod in Myasthenia Gravis. Neurology Neuroimmunology & Neuroinflammation. 12(1). e200331–e200331. 5 indexed citations
4.
Narayanaswami, Pushpa, et al.. (2024). App- and Wearable-Based Remote Monitoring for Patients With Myasthenia Gravis and Its Specialists: Feasibility and Usability Study. JMIR Formative Research. 9. e58266–e58266. 1 indexed citations
5.
Lehnerer, Sophie, Lea Gerischer, Frauke Stascheit, et al.. (2024). Burden of disease in Lambert-Eaton myasthenic syndrome: taking the patient’s perspective. Journal of Neurology. 271(5). 2824–2839. 1 indexed citations
6.
Annane, Djillali, Andreas Meisel, Masahisa Katsuno, et al.. (2024). P.053 Concomitant corticosteroid use in ravulizumab-treated adults with anti-AChR antibody-positive gMG: results from the CHAMPION MG open-label extension. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. 51(s1). S30–S30. 1 indexed citations
7.
Hotter, Benjamin, Christian H. Nolte, Jan F. Scheitz, et al.. (2023). Machine learning using multimodal and autonomic nervous system parameters predicts clinically apparent stroke-associated pneumonia in a development and testing study. Journal of Neurology. 271(2). 899–908. 11 indexed citations
8.
Palà, Elena, Anna Peñalba, Alejandro Bustamante, et al.. (2023). Blood biomarker changes following therapeutic hypothermia in ischemic stroke. Brain and Behavior. 13(11). e3230–e3230. 3 indexed citations
9.
Dewilde, Sarah, Mathieu F. Janssen, Fiammetta Vanoli, et al.. (2023). Concordance between patient‐ and physician‐reported Myasthenia Gravis Activities of Daily Living (MG‐ADL) scores. Muscle & Nerve. 68(1). 65–72. 5 indexed citations
10.
Vu, Tuan, Andreas Meisel, Renato Mantegazza, et al.. (2023). Summary of Research: Terminal Complement Inhibitor Ravulizumab in Generalized Myasthenia Gravis. Neurology and Therapy. 12(5). 1435–1438. 14 indexed citations
11.
Rieckmann, Nina, et al.. (2022). Development of a patient-oriented navigation model for patients with lung cancer and stroke in Germany. BMC Health Services Research. 22(1). 785–785. 9 indexed citations
12.
Gerischer, Lea, Franziska Scheibe, Astrid Nümann, et al.. (2021). Acute porphyrias – A neurological perspective. Brain and Behavior. 11(11). e2389–e2389. 25 indexed citations
13.
García‐Berrocoso, Teresa, Elena Palà, Benedetta Piccardi, et al.. (2019). Cardioembolic Ischemic Stroke Gene Expression Fingerprint in Blood: a Systematic Review and Verification Analysis. Translational Stroke Research. 11(3). 326–336. 18 indexed citations
14.
Köhler, Siegfried, Stefanie Märschenz, Ulrike Grittner, et al.. (2019). Bortezomib in antibody-mediated autoimmune diseases (TAVAB): study protocol for a unicentric, non-randomised, non-placebo controlled trial. BMJ Open. 9(1). e024523–e024523. 40 indexed citations
15.
16.
Nave, Alexander H., Jan Kröber, Peter Brunecker, et al.. (2013). Biomarkers and perfusion – training-induced changes after stroke (BAPTISe): protocol of an observational study accompanying a randomized controlled trial. BMC Neurology. 13(1). 197–197. 10 indexed citations
17.
Hotter, Benjamin, Jens Steinbrink, W. U. Schmidt, et al.. (2013). Impact of Selection Criteria on Recruitment in an Interventional Stroke Trial. Cerebrovascular Diseases. 36(5-6). 344–350. 7 indexed citations
18.
Zwam, Marloes van, Ruth Huizinga, Marie‐José Melief, et al.. (2008). Brain antigens in functionally distinct antigen-presenting cell populations in cervical lymph nodes in MS and EAE. Journal of Molecular Medicine. 87(3). 273–286. 118 indexed citations
19.
Kunz, Andrea, et al.. (1998). An experimental selection system to identify bacterial cells exhibiting a new DNA host specificity.. PubMed. 379(4-5). 563–6.
20.
Meisel, Andreas, Detlev H. Krüger, & Thomas A. Bickle. (1991). M.EcoPl5 methylates the second adenine in its recognition sequence. Nucleic Acids Research. 19(14). 3997–3997. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Christoph Kleinschnitz Breakdown of academic impact, for papers by José Castillo Breakdown of academic impact, for papers by Anna M. Planas Breakdown of academic impact, for papers by Klaus Faßbender Breakdown of academic impact, for papers by Matthias Endres Breakdown of academic impact, for papers by Patricia D. Hurn Breakdown of academic impact, for papers by Gary A. Rosenberg Breakdown of academic impact, for papers by Chung Y. Hsu Breakdown of academic impact, for papers by Jacques De Keyser Breakdown of academic impact, for papers by Josef Anrather
Rankless by CCL
2026